Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-08

Clinical Trial Update: A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo [Phase 4]

View source ↗

Summary

Phase 4 trial comparing oral ibandronate to placebo in women with osteoporosis has completed. The study assessed the quality and strength of bone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Boniva (ibandronate)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED